NBTX News and Press, Nanobiotix S.A.

A look at the top 10 most actives in the United States Autozi Internet Technology (Global) Ltd. (AZI) rose 146.4% to $0.65 on volume of 528,049,630 shares Elong Power Holding Limited (ELPW) rose 6.7% to $0.048 on volume of 380,279,563 shares EON Resources Inc. Class A (EONR) rose 19.4% to $...

A look at the top 10 most actives in the United States Actelis Networks Inc (ASNS) rose 194.6% to $0.5545 on volume of 1,008,694,275 shares Decent Holding Inc. (DXST) rose 154.8% to $0.2069 on volume of 907,543,553 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.3% to $1.93...

PARIS and CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “ Company ”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other majo...

PARIS and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities...

2025-11-24 16:22:24 ET More on Nanobiotix Nanobiotix S.A.: Behind The Recent Momentum Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case Nanobiotix S.A. (NBTX) Discusses on New Phase 1 Results In Metastatic Melanoma Conference Nanobioti...

Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty (“HCRx”) of a non-dilutive royalty financing valued up to $71 million Progress in the JNJ-1900 (NBTXR3) global development program announced including first data from...

2025-11-24 10:29:00 ET Nanobiotix (NASDAQ: NBTX) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering if such torrid growth could continue. Well, it could -- because the company ...

Four new patent applications filed that aim to expand the Curadigm Nanoprimer platform intellectual property portfolio and support an initial proprietary internal pipeline of Nanoprimer products in addition to external collaborations New in vivo pre-clinical data evaluating the Nanoprimer...

PARIS and CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “ Company ”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and ot...

PARIS and CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “ Company ”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and ot...